©The Author(s) 2021.
World J Exp Med. Mar 20, 2021; 11(2): 17-29
Published online Mar 20, 2021. doi: 10.5493/wjem.v11.i2.17
Published online Mar 20, 2021. doi: 10.5493/wjem.v11.i2.17
Table 2 Study population
| Frequency | Percent | ||
| Age | 20.00 | 1 | 11.1 |
| 25.00 | 1 | 11.1 | |
| 27.00 | 1 | 11.1 | |
| 29.00 | 1 | 11.1 | |
| 34.00 | 1 | 11.1 | |
| 37.00 | 1 | 11.1 | |
| 43.00 | 1 | 11.1 | |
| 51.00 | 1 | 11.1 | |
| Sex | M | 8 | 100.0 |
| F | 0 | 0 | |
| Cause of hypoxia | Cardiac arrest | 1 | 12.5 |
| Cardiac arrest due to acute myocard infarction | 3 | 37.5 | |
| Cardiac arrest due to explosive devices injury | 1 | 12.5 | |
| Cardiac arrest due to multi-trauma | 1 | 12.5 | |
| Cardiac arrest, unkown ethiology | 2 | 25.0 | |
| Duration of hypoxia | 25.00 | 1 | 12.5 |
| 30.00 | 1 | 12.5 | |
| 40.00 | 1 | 12.5 | |
| 45.00 | 3 | 37.5 | |
| 60.00 | 1 | 12.5 | |
| 75.00 | 1 | 12.5 | |
| Previous treatment | No | 8 | 100.0 |
| Yes | 0 | 0 | |
| Comorbidity | Atrial fibrilation | 1 | 12.5 |
| No | 7 | 87.5 | |
| Duration between hypoxia and first SCT | 6.00 | 3 | 37.5 |
| 10.00 | 1 | 12.5 | |
| 11.00 | 1 | 12.5 | |
| 18.00 | 2 | 25.0 | |
| 96.00 | 1 | 12.5 | |
- Citation: Kabataş S, Civelek E, Kaplan N, Savrunlu EC, Sezen GB, Chasan M, Can H, Genç A, Akyuva Y, Boyalı O, Diren F, Karaoz E. Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy. World J Exp Med 2021; 11(2): 17-29
- URL: https://www.wjgnet.com/2220-315x/full/v11/i2/17.htm
- DOI: https://dx.doi.org/10.5493/wjem.v11.i2.17